(TRDA) Entrada Therapeutics - Performance -48.8% in 12m
TRDA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-53.04%
#77 in Peer-Group
Rel. Strength
9.33%
#6959 in Stock-Universe
Total Return 12m
-48.83%
#128 in Peer-Group
Total Return 5y
-69.81%
#79 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 12.2 |
| P/E Forward | 3.33K |
| High / Low | USD |
|---|---|
| 52 Week High | 21.59 USD |
| 52 Week Low | 6.72 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 53.11 |
| Buy/Sell Signal +-5 | -0.72 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TRDA (-48.8%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: TRDA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TRDA
| Total Return (including Dividends) | TRDA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.83% | 3.36% | 5.25% |
| 3 Months | -8.94% | 15.73% | 24.13% |
| 12 Months | -48.83% | -7.02% | 14.15% |
| 5 Years | -69.81% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | TRDA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -77% | 4.4% | 81% |
| 3 Months | -59.8% | 78.8% | 96.9% |
| 12 Months | -75.6% | -85.8% | 44.9% |
| 5 Years | 2.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th28.00 | -11.79% | -13.37% |
| 3 Month | %th20.00 | -21.32% | -26.64% |
| 12 Month | %th36.00 | -44.97% | -55.18% |
| 5 Years | %th62.00 | -55.88% | -78.98% |
FAQs
Does Entrada Therapeutics (TRDA) outperform the market?
No,
over the last 12 months TRDA made -48.83%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months TRDA made -8.94%, while XBI made 15.73%.
Performance Comparison TRDA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TRDA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.9% | -14.1% | -65.6% | -63% |
| US NASDAQ 100 | QQQ | 3.2% | -14.1% | -66.3% | -62% |
| German DAX 40 | DAX | 5.1% | -7.4% | -77.8% | -78% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.1% | -12.1% | -69% | -69% |
| Hongkong Hang Seng | HSI | 3.3% | -14.9% | -85.1% | -87% |
| India NIFTY 50 | INDA | 4.8% | -12.3% | -65.9% | -48% |
| Brasil Bovespa | EWZ | 0.5% | -17.6% | -90.7% | -59% |
TRDA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.3% | -14.7% | -69.7% | -73% |
| Consumer Discretionary | XLY | 3.4% | -12% | -58% | -67% |
| Consumer Staples | XLP | 2.6% | -9.5% | -67.3% | -58% |
| Energy | XLE | 2.6% | -15.9% | -61.5% | -49% |
| Financial | XLF | 2.2% | -13.9% | -70.5% | -79% |
| Health Care | XLV | 3.5% | -11% | -58.3% | -44% |
| Industrial | XLI | 2.8% | -13% | -73.5% | -74% |
| Materials | XLB | 0.7% | -13.1% | -70.1% | -55% |
| Real Estate | XLRE | 3% | -9.8% | -65.3% | -62% |
| Technology | XLK | 2.2% | -17.5% | -67.9% | -60% |
| Utilities | XLU | 4% | -10.6% | -68.8% | -72% |
| Aerospace & Defense | XAR | 5.1% | -15.9% | -84.2% | -98% |
| Biotech | XBI | 1.9% | -12.2% | -52.4% | -42% |
| Homebuilder | XHB | 0.4% | -15.9% | -58.4% | -54% |
| Retail | XRT | 0.4% | -13.8% | -61.3% | -60% |
TRDA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2% | -17.3% | -57.2% | -41% |
| Natural Gas | UNG | 12.4% | 1% | -48.8% | -47% |
| Gold | GLD | 2.7% | -7.6% | -86.2% | -88% |
| Silver | SLV | 1.9% | -15.8% | -83% | -66% |
| Copper | CPER | 3.9% | -13.4% | -82.7% | -60% |
TRDA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.7% | -9.9% | -62.2% | -47% |
| iShares High Yield Corp. Bond | HYG | 4.1% | -10.4% | -64.5% | -59% |